CytomX Therapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
South San Francisco, CA
SEC filing record 1 source field available
Fiscal year end
31 December
CytomX Therapeutics, Inc. has filed 794 SEC EDGAR filings since 28 Sep 2010

SEC filing history

Showing 526-550 of 794 matching filings.

Per page
25
Current page
22
4

FORM 4

Filing date
04 Apr 2018
Reporting date
02 Apr 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
27 Mar 2018
Reporting date
26 Mar 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K/A File 001-37587

10-K/A

Filing date
14 Mar 2018
Reporting date
31 Dec 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37587

8-K

Filing date
07 Mar 2018
Reporting date
07 Mar 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-223491

S-8

Filing date
07 Mar 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
05 Mar 2018
Reporting date
02 Mar 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
05 Mar 2018
Reporting date
02 Mar 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
05 Mar 2018
Reporting date
01 Mar 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
05 Mar 2018
Reporting date
01 Mar 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
02 Mar 2018
Reporting date
28 Feb 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
02 Mar 2018
Reporting date
28 Feb 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-89140

AMENDMENT NO. 1 TO THE SCHEDULE 13G

Filing date
14 Feb 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-89140

AMENDMENT NO 1 TO SCHEDULE 13G

Filing date
14 Feb 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-89140

SCHEDULE 13G AMENDMENT 1

Filing date
13 Feb 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-89140

SC 13G/A

Filing date
13 Feb 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-89140

SC 13G/A filing

Filing date
13 Feb 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
5

FORM 5

Filing date
12 Feb 2018
Reporting date
31 Dec 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
02 Feb 2018
Reporting date
01 Feb 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-89140

SC 13G filing

Filing date
01 Feb 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37587

FORM 8-K

Filing date
29 Jan 2018
Reporting date
24 Jan 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
26 Jan 2018
Reporting date
24 Jan 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
26 Jan 2018
Reporting date
24 Jan 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
26 Jan 2018
Reporting date
24 Jan 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
26 Jan 2018
Reporting date
24 Jan 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .